Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
Kadidja Gamougam;
Doumagoum M Daugla;
Jacques Toralta;
Cyriaque Ngadoua;
Florence Fermon;
Anne-Laure Page;
Mamoudou H Djingarey;
Dominique A Caugant;
Olivier Manigart;
Caroline L Trotter;
+2 more...
James M Stuart;
Brian M Greenwood 
;
(2015)
Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
Emerging infectious diseases, 21 (1).
pp. 115-118.
ISSN 1080-6040
DOI: 10.3201/eid2101.140256
;
(2015)
Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
Emerging infectious diseases, 21 (1).
pp. 115-118.
ISSN 1080-6040
DOI: 10.3201/eid2101.140256
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.
-
picture_as_pdf - 14-0256.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads